A progress report of a phase I study of interferon-gamma and interleukin-2 and some comments on the mechanism of the toxicity due to interleukin-2.
Wagstaff
J
J
Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
Vermorken
J B
JB
Schwartsmann
G
G
Scheper
R J
RJ
Hack
C E
CE
Nuijens
J H
JH
Eerenberg-Belmer
A J
AJ
Pinedo
H M
HM
D000328:Adult; D000368:Aged; D003167:Complement Activation; D004341:Drug Evaluation; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology
D007376:Interleukin-2; D007371:Interferon-gamma